511 related articles for article (PubMed ID: 29107561)
1. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
[TBL] [Abstract][Full Text] [Related]
2. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
Kelly H; Chikandiwa A; Alemany Vilches L; Palefsky JM; de Sanjose S; Mayaud P
Lancet HIV; 2020 Apr; 7(4):e262-e278. PubMed ID: 32109408
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral Therapy and Detection of High-grade Cervical Intraepithelial Neoplasia (CIN2+) at Post-CIN Management Follow-up Among Women Living With Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Atemnkeng N; Aji AD; de Sanjose S; Mayaud P; Kelly H
Clin Infect Dis; 2020 Dec; 71(10):e540-e548. PubMed ID: 32162657
[TBL] [Abstract][Full Text] [Related]
4. The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
Gilles C; Konopnicki D; Rozenberg S
HIV Med; 2023 Aug; 24(8):877-892. PubMed ID: 37062862
[TBL] [Abstract][Full Text] [Related]
5. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
Videla S; Tarrats A; Ornelas A; Badia R; Castella E; Alcalde C; Chamorro A; Esté JA; Clotet B; Sirera G
Int J STD AIDS; 2019 Jan; 30(1):56-63. PubMed ID: 30170532
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
9. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
[TBL] [Abstract][Full Text] [Related]
11. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
12. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
[TBL] [Abstract][Full Text] [Related]
13. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
Palefsky JM
Curr Opin Oncol; 2003 Sep; 15(5):382-8. PubMed ID: 12960521
[TBL] [Abstract][Full Text] [Related]
14. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.
Menon S; Luchters S; Rossi R; Callens S; Kishor M; Bogers J; Vanden Broeck D
Virol J; 2018 Mar; 15(1):54. PubMed ID: 29587796
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.
De Vuyst H; Mugo NR; Chung MH; McKenzie KP; Nyongesa-Malava E; Tenet V; Njoroge JW; Sakr SR; Meijer CM; Snijders PJ; Rana FS; Franceschi S
Br J Cancer; 2012 Oct; 107(9):1624-30. PubMed ID: 23033006
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
20. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
